Preferred Label : R-ESHAP Regimen;
NCIt synonyms : Rituximab/Etoposide/Solumedrol/High-dose Cytarabine/Cisplatin; Etoposide/Methylprednisolone/High-dose Cytarabine/Cisplatin; Rituximab-Etoposide-Solu-Medrol-High-dose Ara-C-Platinol; Rituximab-Etoposide-Methylprednisolone-High-dose Cytarabine-Cisplatin; ESHAP-R; Etoposide/Methylprednisolone/Cytarabine/Cisplatin Plus Rituximab; Cytarabine/Cisplatin/Etoposide/Methylprednisolone/Rituximab; Cytarabine/Cisplatin/Etoposide/Methylprednisolone/Rituxan; Cytarabine-Cisplatin-Etoposide-Methylprednisolone-Rituximab; ESHAP Plus Rituximab; Etoposide-Solumedrol-High Dose Ara-C-Platinol-Rituximab Regimen; Etoposide/Solumedrol/High Dose Ara-C/Platinol/Rituximab Regimen;
NCIt related terms : R-ESHAP; R-ESHAP (rituximab-arrx); R-ESHAP (rituximab-blit); R-ESHAP (rituximab-pvvr); R-ESHAP (rituximab-rixa); R-ESHAP (rituximab-abbs); R-ESHAP (rituximab-rite); R-ESHAP (rituximab-rixi);
NCIt definition : A regimen consisting of rituximab, etoposide, methylprednisolone, high-dose cytarabine
and cisplatin that can be used in the treatment of Hodgkin lymphoma (HL) and non-Hodgkin
lymphoma (NHL), including diffuse large B-cell lymphoma.;
NCI Metathesaurus CUI : CL538185;
Codes from synonyms : 16328; 128737; 127795; 128423; 127952; 128109; 128580; 128266;
Origin ID : C140099;
UMLS CUI : C4682701;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
